In our model, we see the most significant inflammation after 49 weeks of HF–HC–HSD, where there is an increase in both endotoxin and IL-1β, which may the necessary mediators for NASH progression. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.